Skip to main content
. 2023 Jan 4;2023:9990843. doi: 10.1155/2023/9990843

Figure 3.

Figure 3

Effect of DoMRE on XOD and ADA activity. (a) The XOD activity in the serum after 12-week oral administration. (b) The XOD activity in the liver after 12-week oral administration. (c) The XOD activity in the small intestine after 12-week oral administration. (d) The ADA activity in the serum after 12-week oral administration. (e) The ADA activity in the liver after 12-week oral administration. (f) The ADA activity in the small intestine after 12-week oral administration. NC, normal control group; MC, model control group; DoMRE-L, low dose of DoMRE group; DoMRE-H, high dose of DoMRE group. The data were expressed as mean ± SD of 8 rats in each group. #P < 0.05; ##P < 0.01, compared with NC group; ∗P < 0.05; ∗∗P < 0.01, compared with MC group.